Director/PDMR Shareholding

Assura PLC
21 December 2023
 

21 December 2023

Assura plc

("the Company")

Notification of transaction by Persons Discharging Managerial Responsibilities ("PDMRs") and connected persons

The Company announces the following transactions in respect of Ordinary Shares of 10 pence each in the Company ("Ordinary Shares"):

·    Jonathan Murphy's spouse has transferred 252,000 Ordinary Shares into his ISA

·    Jonathan Murphy's spouse has transferred 322,000 Ordinary Shares into her ISA

Following the transactions, the total beneficial interest of Jonathan Murphy and his connected persons in the Ordinary Shares is unchanged at 2,944,180.

The Notification of Dealing Forms can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Murphy

2

Reason for the notification

 

a)

Position/status

 

CEO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Transfer of shares from Spouse into his ISA

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.4808 GBP

 

252,000

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4808 GBP

 

 

252,000

 

£121,161.6 GBP

e)

Date of the transaction

 

21/12/2023

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Murphy

2

Reason for the notification

 

a)

Position/status

 

CEO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Transfer of shares by Spouse into her ISA

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.4808 GBP

 

322,000

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4808 GBP

 

 

322,000

 

£154,817.60 GBP

e)

Date of the transaction

 

21/12/2023

f)

Place of the transaction

 

XLON

- Ends -

For further information, please contact:

Assura plc
Orla Ball, Company Secretary
David Purcell, Investor Relations Director

Tel: 0161 515 2043
Email: Investor@assura.co.uk

Finsbury Glover Hering

Gordon Simpson

Tel: 0207 251 3801
Email: Assura@FGSGlobal.com

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Assura (AGR)
UK 100

Latest directors dealings